304 related articles for article (PubMed ID: 22795392)
1. Yawning as a dose-dependent side effect of treatment with escitalopram.
Roncero C; Mezzatesta-Gava M; Grau-López L; Daigre C
Neurologia; 2013; 28(9):589-90. PubMed ID: 22795392
[No Abstract] [Full Text] [Related]
2. Attention to side effects enhances medical adherence.
Vinberg M
Acta Psychiatr Scand; 2007 Jan; 115(1):82. PubMed ID: 17201871
[No Abstract] [Full Text] [Related]
3. Do your patients suffer from excessive yawning?
Gutiérrez-Alvarez AM
Acta Psychiatr Scand; 2007 Jan; 115(1):80-1. PubMed ID: 17201870
[TBL] [Abstract][Full Text] [Related]
4. Emergence of electric shock-like sensations on escitalopram discontinuation.
Prakash O; Dhar V
J Clin Psychopharmacol; 2008 Jun; 28(3):359-60. PubMed ID: 18480703
[No Abstract] [Full Text] [Related]
5. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.
Mundo E; Bianchi L; Bellodi L
J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram-associated serotonin toxicity.
Vari G; Beckson M
J Clin Psychopharmacol; 2007 Apr; 27(2):229-30. PubMed ID: 17414259
[No Abstract] [Full Text] [Related]
7. Visual and auditory hallucinations associated with citalopram treatment.
Waltereit R; Eifler S; Schirmbeck F; Zink M
J Clin Psychopharmacol; 2013 Aug; 33(4):583-4. PubMed ID: 23775056
[No Abstract] [Full Text] [Related]
8. High-dose escitalopram treatment in patients with obsessive-compulsive disorder: a naturalistic case series.
Shim GS; Kang DH; Kwon JS
J Clin Psychopharmacol; 2008 Feb; 28(1):108-10. PubMed ID: 18204356
[No Abstract] [Full Text] [Related]
9. Escitalopram in the treatment of obsessive-compulsive disorder.
Zohar J
Expert Rev Neurother; 2008 Mar; 8(3):339-49. PubMed ID: 18345966
[TBL] [Abstract][Full Text] [Related]
10. Escitalopram.
Aronson S; Delgado P
Drugs Today (Barc); 2004 Feb; 40(2):121-31. PubMed ID: 15045034
[TBL] [Abstract][Full Text] [Related]
11. Considerations on safety concerns about citalopram prescribing.
Sheeler RD; Ackerman MJ; Richelson E; Nelson TK; Staab JP; Tangalos EG; Dieser LM; Cunningham JL
Mayo Clin Proc; 2012 Nov; 87(11):1042-5. PubMed ID: 23018033
[No Abstract] [Full Text] [Related]
12. Citalopram in refractory obsessive-compulsive disorder: an open study.
Marazziti D; Dell'Osso L; Gemignani A; Ciapparelli A; Presta S; Nasso ED; Pfanner C; Cassano GB
Int Clin Psychopharmacol; 2001 Jul; 16(4):215-9. PubMed ID: 11459335
[TBL] [Abstract][Full Text] [Related]
13. Carcinoid tumor, selective serotonin reuptake inhibitors, and diarrhea.
Simbera Z; Balon R
Psychosomatics; 2005; 46(1):88-9. PubMed ID: 15765829
[No Abstract] [Full Text] [Related]
14. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.
Koponen H; Lepola U; Leinonen E; Jokinen R; Penttinen J; Turtonen J
Acta Psychiatr Scand; 1997 Nov; 96(5):343-6. PubMed ID: 9395151
[TBL] [Abstract][Full Text] [Related]
15. [Citalopram].
El-Armouche A; Zolk O; Eschenhagen T
Dtsch Med Wochenschr; 2003 Oct; 128(43):2253-6. PubMed ID: 14574639
[No Abstract] [Full Text] [Related]
16. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.
Lepola UM; Loft H; Reines EH
Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155
[TBL] [Abstract][Full Text] [Related]
17. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Benazzi F
Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
[No Abstract] [Full Text] [Related]
18. [SSRI-induced akathesia].
Hofmann M; Vidoni F
Psychiatr Prax; 1996 May; 23(3):143-4. PubMed ID: 8711007
[No Abstract] [Full Text] [Related]
19. [Clinical efficacy of citalopram in patients with obsessive-compulsive disorder].
Jakitowicz J; Nowicki Z; Wiśniewski G
Psychiatr Pol; 2002; 36(6 Suppl):297-301. PubMed ID: 12647452
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy.
Stein DJ; Carey PD; Lochner C; Seedat S; Fineberg N; Andersen EW
CNS Spectr; 2008 Jun; 13(6):492-8. PubMed ID: 18567973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
